Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors. - Piha-Paul SA; Hann CL; French CA; Cousin S; Braña I; Cassier PA; Moreno V; de Bono JS; Harward SD; Ferron-Brady G; Barbash O; Wyce A; et al. (JNCI cancer spectrum, 2019)